
Colchicine for CV Reduction Splits Cardiologists
While conducting the CLEAR SYNERGY (OASIS 9) trial, lead author Sanjit Jolly, MD continued to treat some of his patients with post–myocardial infarction (MI), including his late father, with colchicine. Then the trial showed that the anti-inflammatory drug …